Prospects for a hepcidin mimic to treat β-thalassemia and hemochromatosis

Anemia of Inflammation

(2011) C. N. Roy   Hematology-American Society of Hematology Education Program

Hepcidin and Disorders of Iron Metabolism

(2010) Tomas Ganz et al.   Annual Review of Medicine

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

(2010) K. Maes et al.   BLOOD

Hepcidin treatment in Hfe−/− mice diminishes plasma iron without affecting erythropoiesis

(2010) María-Josefa Morán-Jiménez et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone

(2010) Bomee Chung et al.   FASEB JOURNAL

BMP6 Treatment Compensates for the Molecular Defect and Ameliorates Hemochromatosis in Hfe Knockout Mice

(2010) Elena Corradini et al.   GASTROENTEROLOGY

Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment

(2010) Antonello Pietrangelo   GASTROENTEROLOGY

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

(2010) Sara Gardenghi et al.   JOURNAL OF CLINICAL INVESTIGATION

Hepcidin in human iron disorders: Therapeutic implications

(2010) Antonello Pietrangelo   JOURNAL OF HEPATOLOGY

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

(2010) Marina Cavazzana-Calvo et al.   NATURE

Transferrin therapy ameliorates disease in β-thalassemic mice

(2010) Huihui Li et al.   NATURE MEDICINE

Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells

(2009) T. Tanno et al.   BLOOD